These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26423888)

  • 1. Precision of the Kalon Herpes Simplex Virus Type 2 IgG ELISA: an international inter-laboratory assessment.
    Patel EU; Manucci J; Kahle EM; Lingappa JR; Morrow RA; Piwowar-Manning E; James A; Maluzi KF; Cheeba MM; Gray G; Kosloff B; Delany-Moretlwe S; Inambao M; Vwalika B; Quinn TC; Laeyendecker O
    BMC Infect Dis; 2015 Sep; 15():398. PubMed ID: 26423888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
    Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
    Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
    Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
    Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis.
    Biraro S; Mayaud P; Morrow RA; Grosskurth H; Weiss HA
    Sex Transm Dis; 2011 Feb; 38(2):140-7. PubMed ID: 20706175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2.
    LeGoff J; Mayaud P; Gresenguet G; Weiss HA; Nzambi K; Frost E; Pepin J; Belec L;
    J Clin Microbiol; 2008 Jun; 46(6):1914-8. PubMed ID: 18385443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.
    De Baetselier I; Menten J; Cuylaerts V; Ahmed K; Deese J; Van Damme L; Crucitti T
    PLoS One; 2015; 10(3):e0120207. PubMed ID: 25799522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of HSV-2 type specific serological tests in men in Kenya.
    Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
    J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the HerpeSelect (Focus) and Kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil.
    Nascimento MC; Ferreira S; Sabino E; Hamilton I; Parry J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Jul; 45(7):2309-11. PubMed ID: 17507516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa.
    Nasrallah GK; Dargham SR; Sahara AS; Elsidiq MS; Abu-Raddad LJ
    J Clin Virol; 2019 Feb; 111():33-38. PubMed ID: 30639845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries.
    Mujugira A; Morrow RA; Celum C; Lingappa J; Delany-Moretlwe S; Fife KH; Heffron R; De Bruyn G; Homawoo B; Karita E; Mugo N; Vwalika B; Baeten JM;
    Sex Transm Infect; 2011 Apr; 87(3):238-41. PubMed ID: 21307152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of ELISA and Western blot to detect antibodies against HSV-2 using dried blood spots.
    García-Cisneros S; Sánchez-Alemán MÁ; Conde-Glez CJ; Lara-Zaragoza SJ; Herrera-Ortiz A; Plett-Torres T; Olamendi-Portugal M
    J Infect Public Health; 2019; 12(2):224-228. PubMed ID: 30389368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda.
    Gamiel JL; Tobian AA; Laeyendecker OB; Reynolds SJ; Morrow RA; Serwadda D; Gray RH; Quinn TC
    Clin Vaccine Immunol; 2008 May; 15(5):888-90. PubMed ID: 18321879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.
    Arvaja M; Lehtinen M; Koskela P; Lappalainen M; Paavonen J; Vesikari T
    Sex Transm Infect; 1999 Jun; 75(3):168-71. PubMed ID: 10448394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
    Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
    Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.
    Morrow RA; Friedrich D; Krantz E
    J Clin Microbiol; 2003 Nov; 41(11):5212-4. PubMed ID: 14605166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.
    Laderman EI; Whitworth E; Dumaual E; Jones M; Hudak A; Hogrefe W; Carney J; Groen J
    Clin Vaccine Immunol; 2008 Jan; 15(1):159-63. PubMed ID: 18003814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
    Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
    Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disclosure of HSV-2 serological test results in the context of an adolescent HIV prevention trial in Kenya.
    Hallfors DD; Cho H; Mbai II; Millimo BW; Atieno C; Okumu D; Luseno WK; Hartman S; Halpern CT; Hobbs MM
    Sex Transm Infect; 2015 Sep; 91(6):395-400. PubMed ID: 26139208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.
    Eing BR; Lippelt L; Lorentzen EU; Hafezi W; Schlumberger W; Steinhagen K; Kühn JE
    J Clin Microbiol; 2002 Feb; 40(2):407-13. PubMed ID: 11825950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.
    Liu T; Liu JF; Yu H; Si GJ; Hu J; Li J
    Singapore Med J; 2015 Jun; 56(6):346-52. PubMed ID: 25532518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.